SYK and pancreatic neoplasm: Notably, a separate report indicates that tumor-associated macrophages expressing Siglec-15 in the microenvironment of pancreatic cancer exhibit a distinct immunosuppressive phenotype that is sustained by SYK/MAPK activation associated with Siglec-15 [68].